Michael McGuffin, President of the American Herbal Products Association (AHPA), joined U.S. Hemp Roundtable General Counsel, Jonathan Miller, to discuss the recent New Dietary Ingredient Notifications (NDINs) submitted on behalf of #hemp-derived extracts rejected by the U.S. Federal Drug Administration (FDA) and the possible regulatory pathways for products containing these ingredients.
Excerpt only …
READ MORE BELOW
Source : September 14 2021: USHempTV: FDA NDIN Rejections and Regulatory Pathways for Hemp-Derived CBD
reposted by Cannabis News World